
|Articles|November 15, 2016
- Pharmaceutical Technology-11-15-2016
- Volume 2016 eBook
- Issue 3
Microbiological Testing: Time is of the Essence
Author(s)Cynthia A. Challener
Pressures to accelerate current and next-gen therapies are challenging traditional microbiological testing models.
Advertisement
Effective microbiological testing during biopharmaceutical drug development and manufacturing is crucial for ensuring sterility, determining antimicrobial effectiveness, detecting microbial contamination or bioburden levels, analyzing endotoxins, and implementing environmental monitoring programs.
Growing pressures to increase productivity, flexibility, and cost-effectiveness and the unique properties of many next-generation therapies are challenging today’s microbiologists.
Download Pharmaceutical Technology’s
.
Articles in this issue
over 9 years ago
Extending QMS to Contract Partnersover 9 years ago
Investigation Effectiveness Drives Human Performance Excellenceover 9 years ago
Is Global Regulatory Gridlock Slowing Modernization?over 9 years ago
Paperless Batch Records for the Massesover 9 years ago
Ensuring Quality in Pharmaceutical Raw MaterialsAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory
2
FDA Activity Round Up – July 2026
3
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
4
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
5





